Saturday - August 2, 2025
Cogent Biosciences Closes $230 Million Upsized Public Offering of Common Stock
July 24, 2025
BOSTON, Massachusetts, July 24 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Cogent Biosciences Closes $230 Million Upsized Public Offering of Common Stock

*

Deal follows Cogent's positive top-line results from SUMMIT registrational trial of bezuclastinib in patients with NonAdvanced Systemic Mastocytosis meeting all primary and key secondary endpoints with statistical significance

. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products